ProPhase Labs, Inc. Common Stock (DE)
Symbol: PRPH (NASDAQ)
Company Description:
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.
- Today's Open: $0.3202
- Today's High: $0.353
- Today's Low: $0.305
- Today's Volume: 3.58M
- Yesterday Close: $0.3325
- Yesterday High: $0.3441
- Yesterday Low: $0.31
- Yesterday Volume: 3.43M
- Last Min Volume: 2.06K
- Last Min High: $0.345
- Last Min Low: $0.345
- Last Min VWAP: $0.345
- Name: ProPhase Labs, Inc. Common Stock (DE)
- Website: https://www.prophaselabs.com
- Listed Date: 1995-02-01
- Location: NEW YORK, NY
- Market Status: Active
- CIK Number: 0000868278
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $14.51M
- Round Lot: 100
- Outstanding Shares: 41.54M
- Asset Type: CS
Filing Date | Filing Type | Format |
---|---|---|
2025-08-15 | DEF 14A | View |
2025-08-13 | 10-Q | View |
2025-08-13 | 8-K | View |
2025-08-08 | PRER14A | View |
2025-08-06 | 8-K | View |
2025-08-05 | D | View |
2025-07-29 | 8-K | View |
2025-07-28 | PRE 14A | View |
2025-07-28 | 8-K | View |
2025-07-25 | 8-K | View |
2025-07-23 | 8-K | View |
2025-07-21 | 8-K | View |
2025-07-07 | D | View |
2025-07-01 | 8-K | View |
2025-06-27 | 8-K/A | View |
2025-06-26 | 8-K | View |
2025-06-26 | 8-K | View |
2025-06-25 | 8-K | View |
2025-06-23 | DEF 14A | View |
2025-05-20 | 10-Q | View |